NO924650D0 - Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse - Google Patents

Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse

Info

Publication number
NO924650D0
NO924650D0 NO924650A NO924650A NO924650D0 NO 924650 D0 NO924650 D0 NO 924650D0 NO 924650 A NO924650 A NO 924650A NO 924650 A NO924650 A NO 924650A NO 924650 D0 NO924650 D0 NO 924650D0
Authority
NO
Norway
Prior art keywords
dialcoxy
pyridinyl
procedures
preparation
pharmaceutical use
Prior art date
Application number
NO924650A
Other languages
English (en)
Norwegian (no)
Other versions
NO924650L (no
Inventor
Arne Elof Braendstroem
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9002206A external-priority patent/SE9002206D0/xx
Priority claimed from SE9002207A external-priority patent/SE9002207D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO924650L publication Critical patent/NO924650L/no
Publication of NO924650D0 publication Critical patent/NO924650D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO924650A 1990-06-20 1992-12-02 Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse NO924650D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds
SE9002207A SE9002207D0 (sv) 1990-06-20 1990-06-20 New compounds i
PCT/SE1991/000416 WO1991019712A1 (en) 1990-06-20 1991-06-11 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use

Publications (2)

Publication Number Publication Date
NO924650L NO924650L (no) 1992-12-02
NO924650D0 true NO924650D0 (no) 1992-12-02

Family

ID=26660803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924650A NO924650D0 (no) 1990-06-20 1992-12-02 Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse

Country Status (29)

Country Link
US (1) US5430042A (fi)
EP (1) EP0593463B1 (fi)
JP (1) JP3049367B2 (fi)
CN (1) CN1058213A (fi)
AP (1) AP253A (fi)
AT (1) ATE184602T1 (fi)
AU (1) AU649456B2 (fi)
BG (1) BG97198A (fi)
CA (1) CA2083606C (fi)
CZ (1) CZ279434B6 (fi)
DE (1) DE69131627T2 (fi)
EG (1) EG19752A (fi)
ES (1) ES2140391T3 (fi)
FI (1) FI925767A (fi)
HU (1) HUT62882A (fi)
IE (1) IE912026A1 (fi)
IL (1) IL98472A (fi)
IS (1) IS3720A7 (fi)
LV (1) LV10269B (fi)
MA (1) MA22198A1 (fi)
NO (1) NO924650D0 (fi)
NZ (1) NZ238545A (fi)
OA (1) OA09683A (fi)
PL (2) PL166209B1 (fi)
PT (1) PT98036A (fi)
RO (1) RO110497B1 (fi)
TN (1) TNSN91050A1 (fi)
WO (1) WO1991019712A1 (fi)
YU (1) YU104091A (fi)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
TNSN95062A1 (fr) * 1994-05-27 1996-02-06 Astra Ab Nouveaux derives dialkoxy-pyridinyle-benzimidazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SK283626B6 (sk) * 1994-07-08 2003-10-07 Astrazeneca Ab Multijednotková tabletovaná dávková forma, spôsob jej prípravy a jej použitie
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5545661A (en) * 1995-05-16 1996-08-13 Eli Lilly And Company Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
JP2002510293A (ja) * 1997-05-30 2002-04-02 ドクター・レディーズ・リサーチ・ファウンデーション 抗潰瘍剤として新規なベンゾイミダゾール誘導体、それらの製造方法、及びそれらを含有する薬学的組成物
US6313303B1 (en) * 1997-07-11 2001-11-06 Eisai Co., Ltd. Process for the preparation of pyridine derivatives
GB9805558D0 (en) * 1998-03-17 1998-05-13 Knoll Ag Chemical process`
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
ES2192394T3 (es) 1998-08-10 2003-10-01 Winston Pharmateuticals Llc Profarmacos de inhibidores de la bomba de protones.
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
PT1492511E (pt) 2002-04-09 2009-04-09 Flamel Tech Sa Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
KR100788778B1 (ko) * 2002-07-19 2007-12-27 윈스턴 파마슈티컬즈, 엘엘씨 벤즈이미다졸 유도체 및 이들의 프로톤 펌프 억제제의프로드럭으로서의 이용
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
MXPA06003450A (es) 2003-09-26 2006-08-31 Johnson & Johnson Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
US20060241037A1 (en) * 2003-10-03 2006-10-26 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
EP1715861A2 (en) * 2004-02-18 2006-11-02 Allergan, Inc. Compositions comprising prodrugs of proton pump inhibitors
US20070161679A1 (en) * 2004-02-18 2007-07-12 Allergan, Inc. Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
EP1775292B1 (en) * 2004-08-06 2012-06-27 Eisai R&D Management Co., Ltd. Salts of benzimidazole derivative with amines and process for production thereof
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN101453993A (zh) 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PL2046334T3 (pl) 2006-07-25 2015-02-27 Vecta Ltd Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20110009624A9 (en) 2006-10-13 2011-01-13 Masato Ueda Benzimidazole compounds having gastric acid secretion inhibitory action
JP2009196894A (ja) * 2006-10-13 2009-09-03 Eisai R & D Management Co Ltd スルフィニルベンズイミダゾール化合物またはその塩の製造方法
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
MX2011013467A (es) 2009-06-25 2012-02-13 Astrazeneca Ab Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2519229A2 (en) 2009-12-29 2012-11-07 Novartis AG New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8500996D0 (sv) * 1985-03-01 1985-03-01 Haessle Ab Method of treatment
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
WO1989003830A1 (en) * 1987-10-30 1989-05-05 Aktiebolaget Hässle 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss
EP0390842A1 (de) * 1987-12-11 1990-10-10 Byk Gulden Lomberg Chemische Fabrik GmbH Neue benzimidazolderivate
JPH03504497A (ja) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規フルオルアルコキシ化合物
SE8804628D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles

Also Published As

Publication number Publication date
CZ279434B6 (cs) 1995-04-12
IS3720A7 (is) 1991-12-21
DE69131627T2 (de) 2000-04-27
AP9100286A0 (en) 1991-07-31
IL98472A0 (en) 1992-07-15
AU649456B2 (en) 1994-05-26
OA09683A (en) 1993-05-15
CA2083606C (en) 2001-08-21
RO110497B1 (ro) 1996-01-30
IE912026A1 (en) 1992-01-01
LV10269A (lv) 1994-10-20
CA2083606A1 (en) 1991-12-21
CN1058213A (zh) 1992-01-29
PL297294A1 (fi) 1992-07-13
AP253A (en) 1993-05-03
CS189391A3 (en) 1992-06-17
YU104091A (sh) 1994-01-20
EP0593463A1 (en) 1994-04-27
TNSN91050A1 (fr) 1992-10-25
JPH05507714A (ja) 1993-11-04
EP0593463B1 (en) 1999-09-15
DE69131627D1 (de) 1999-10-21
EG19752A (en) 1996-01-31
IL98472A (en) 1995-08-31
PL297295A1 (fi) 1992-07-13
HUT62882A (en) 1993-06-28
MA22198A1 (fr) 1992-04-01
FI925767A0 (fi) 1992-12-18
NZ238545A (en) 1993-08-26
PL165898B1 (pl) 1995-02-28
PT98036A (pt) 1992-03-31
FI925767A (fi) 1992-12-18
NO924650L (no) 1992-12-02
ATE184602T1 (de) 1999-10-15
US5430042A (en) 1995-07-04
WO1991019712A1 (en) 1991-12-26
BG97198A (bg) 1993-12-24
JP3049367B2 (ja) 2000-06-05
HU9204034D0 (en) 1993-03-29
LV10269B (en) 1995-10-20
AU8061791A (en) 1992-01-07
ES2140391T3 (es) 2000-03-01
PL166209B1 (pl) 1995-04-28

Similar Documents

Publication Publication Date Title
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO924775D0 (no) Substituerte benzimidazoler, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
DK609489D0 (da) Imidazolderivater, deres fremstilling og anvendelse
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO891866L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO910003D0 (no) Vitamin e derivater og fremgangsmaate for deres fremstilling.
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
DK461389D0 (da) Quinolyloxazol-2-oner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
NO892494D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK530689D0 (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
NO894103D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO921563L (no) Terapeutisk aktive aminopyrimidinderivater, fremgangsmaatefor deres fremstilling og anvendelse derav
NO911047D0 (no) Labdaner og fremgangsmaate for deres fremstilling.
DK469389D0 (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
NO900252D0 (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
NO903484D0 (no) Substituerte pyrazinderivater og fremgangsmaate for deres fremstilling.
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO924563D0 (no) Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser
NO920258D0 (no) Adenosinderivater, fremgangsmaate for deres fremstilling og anvendelse derav
NO912526L (no) Cefalosporinderivater og fremgangsmaate for deres fremstilling.
DK163589A (da) Sakyomycin e og derivater deraf, deres fremstilling og anvendelse
NO930942D0 (no) Nye 17-beta-oestradiolderivater, fremgangsmaater for deres fremstilling og legemiddel inneholdende disse forbindelser
DK162391D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
DK162291D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne